Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

TransCon hGH

Recombinant protein · Protein replacement · developed by Ascendis Pharma Endocrinology Division

Phase 3 Most advanced trial (none active)
ASND Developer
2 Registered trials

What is TransCon hGH?

TransCon hGH is a once-weekly subcutaneous injection of human growth hormone. It is studied in pediatric growth hormone deficiency, a pituitary and hormone deficiency condition.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Recombinant protein
Mechanism
Protein replacement
Therapy area
Endocrine
Developer
Ascendis Pharma Endocrinology Division A/S (ASND)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 3

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03305016 Phase 3 Growth Hormone Deficiency, Pediatric Completed ASND
NCT02781727 Phase 3 Growth Hormone Deficiency, Pediatric Completed ASND

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Endocrine System DiseasesGrowth Hormone Deficiency, PediatrichGH (Human Growth Hormone)Hormone DeficiencyHormonesPituitary Diseases

More from Ascendis Pharma Endocrinology Division

Lonapegsomatropin FDA approved Navepegritide FDA approved Palopegteriparatide FDA approved TransCon CNP FDA approved ACP-001 Phase 2 Resiquimod Hydrogel-based Phase 1/2 TransCon Treprostinil Phase 1

Sources

Updated Oct 11, 2026. Something wrong or missing? Report it on the ASND page.

Follow ASND, the company behind TransCon hGH

See ASND's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

ASND catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.